Show simple item record

dc.contributor.authorRichter, Johan
dc.contributor.authorLübking, Anna
dc.contributor.authorSöderlund, Stina
dc.contributor.authorLotfi, Kourosh
dc.contributor.authorMarkevärn, Berit
dc.contributor.authorSjälander, Anders
dc.contributor.authorStenke, Leif
dc.contributor.authorDeneberg, Stefan
dc.contributor.authorAhlstrand, Erik
dc.contributor.authorMyhr-Eriksson, Kristina
dc.contributor.authorPanayiotidis, Panayiotis
dc.contributor.authorGedde-Dahl, Tobias
dc.contributor.authorŽáčková, Daniela
dc.contributor.authorMayer, Jiří
dc.contributor.authorOlsson-Strömberg, Ulla
dc.contributor.authorMahon, Francois-Xavier
dc.contributor.authorSaussele, Susanne
dc.contributor.authorHjorth-Hansen, Henrik
dc.contributor.authorKoskenvesa, Perttu
dc.date.accessioned2023-01-13T12:58:30Z
dc.date.available2023-01-13T12:58:30Z
dc.date.created2021-08-09T15:59:50Z
dc.date.issued2021
dc.identifier.citationLeukemia. 2021, 35 2416-2418.en_US
dc.identifier.issn0887-6924
dc.identifier.urihttps://hdl.handle.net/11250/3043390
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleMolecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKIen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber2416-2418en_US
dc.source.volume35en_US
dc.source.journalLeukemiaen_US
dc.identifier.doi10.1038/s41375-021-01173-w
dc.identifier.cristin1924830
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal